The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The role of BMI and age in chemotherapy-induced amenorrhea (CIA) in premenopausal breast cancer (PBC) patients treated with adjuvant FEC100 with or without docetaxel (D).
Monica Verrico
No relevant relationships to disclose
Luigi Rossi
No relevant relationships to disclose
Federica Tomao
No relevant relationships to disclose
Erika Giordani
No relevant relationships to disclose
Eleonora Zaccarelli
No relevant relationships to disclose
ANSELMO PAPA
No relevant relationships to disclose
Martina Strudel
No relevant relationships to disclose
Giulia Rinaldi
No relevant relationships to disclose
Francesca Perrone-Congedi
No relevant relationships to disclose
Davide Caruso
No relevant relationships to disclose
Gian Paolo Spinelli
No relevant relationships to disclose
Carlo Capalbo
No relevant relationships to disclose
Giuseppe Lo Russo
No relevant relationships to disclose
Salvatore Evangelista
No relevant relationships to disclose
Loredana Bianchi
No relevant relationships to disclose
Valeria Stati
No relevant relationships to disclose
Alessandra Anna Prete
No relevant relationships to disclose
Silverio Tomao
No relevant relationships to disclose